GENFIT Company Profile

07:06 EDT 23rd March 2018 | BioPortfolio

GENFIT (Paris:ALGFT) is a biopharmaceutical company focused on the Discovery and Development of drug candidates in strategic therapeutic fields linked to cardiometabolic and neurodegenerative disorders (prediabetes/diabetes, atherosclerosis, dyslipidemia, obesity, Alzheimer’s…). GENFIT uses a multi-pronged approach based on early diagnosis, preventive solutions, and therapeutic treatments to address these major public health concerns and their unmet medical needs. GENFIT’s proprietary research programs and its partnerships with leading pharmaceutical companies, including SANOFI-AVENTIS, SOLVAY GROUP, and SERVIER, have resulted in the creation of a rich and diversified pipeline of drug candidates at different stages of development. GENFIT’s lead proprietary compound, GFT505, is currently in Phase II and two other compounds, in partnership with SANOFI-AVENTIS and SOLVAY, are in the advanced stages of Phase I.


Parc Eurasanté – Lille Métropole
885, avenue Eugène Avinée


Phone: +33 (0)3 20 16 40 00
Fax: +33 (0)3 20 16 40 01

News Articles [15 Associated News Articles listed on BioPortfolio]

Genfit Gets €180M Cash Injection to Bring its Pipeline to Market

Elafibranor, Genfit’s lead candidate, will continue its march towards the market with the added boost of massive financial support. Genfit is a leader in the development of diagnostic tools an...

Genfit May Be Gaining An Edge In NASH Race

With Intercept encountering safety concerns for Ocaliva and mixed data for Gilead's and Allergan's NASH candidates, Genfit may hold an...    

Genfit closes €180mm convertible bond offering

Genfit SA (drug development for metabolic and inflammatory diseases; currently focused on NASH) completed a private offering of €180mm ($213mm) of its 3.5% bonds convertible into new shares and/or e...

NASH Leader goes Pediatric with Clinical Trial Launch in US

The FDA has cleared Genfit to kick off clinical trials to see if its NASH drug, elafibranor, can also help children. Genfit develops diagnostic and therapeutic tools for metabolic and inflammatory d...

NASH Leader Signs Up for EU Project to Fight Deadly Liver Disease

Update 27/11/17: Genfit, the leader in the fight against NASH, has joined the LITMUS study. The company will share its experience and resources with the EU collaboration by contributing samples from i...

Genfit raises EUR180M via bond issue


GENFIT:  ADDITIONAL RESOURCES ALLOCATED TO THE LIQUIDITY AGREEMENT Lille (France), Cambridge (Massachusetts, United States), December 8, 2017 - GENFIT (Euronext: GNFT - ISIN: FR000416...


GENFIT:  ANNOUNCES ITS FINANCIAL CALENDAR FOR 2018 Lille (France), Cambridge (Massachusetts, United States), January 12, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a biopha...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]


GENFIT (Paris:ALGFT) is a biopharmaceutical company focused on the Discovery and Development of drug candidates in strategic therapeutic fields linked to cardiometabolic and neuro...

Bionest Partners Inc.

Bionest Partners Inc. provides strategy consulting services exclusively for the life science industries to help pharmaceutical, biopharmaceutical, diagnostics, biotechnology, and ...

More Information about "GENFIT" on BioPortfolio

We have published hundreds of GENFIT news stories on BioPortfolio along with dozens of GENFIT Clinical Trials and PubMed Articles about GENFIT for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GENFIT Companies in our database. You can also find out about relevant GENFIT Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record